Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 64-70

  Furumitsu, Yutaka ^a   Inaba, Masaaki ^b   Yukioka, Kazuhiko ^a   Yukioka, Masao ^a   Kumeda, Yasuro ^b   Azuma, Yoshlaki ^c   Ohta, Tomohiro ^c   Ochi, Takahiro ^d   Nishizawa, Yoshiki ^b   Morii, Hirotoshi ^b  

^a Yukioka Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TEIJIN LTD   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cytokines; Deoxypyridinoline; Pyridinium crosslinks; Pyridinoline; Rheumatoid arthritis

Indexed keywords

DEOXYPYRIDINOLINE; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ARTICULAR CARTILAGE; BLOOD SAMPLING; BONE DENSITY; CROSS LINKING; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; RELIABILITY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; URINARY EXCRETION;

EID: 0033972172     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sambrook PN, Reeve J. Bone disease in rheumatoid arthritis. Clin Sci 1988;74:225-30.
2. Robins SP, Stewart P, Astbury C, Bird HA. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis 1986;45:969-73.
3. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
4. Seibel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. J Rheumatol 1989;16:964-70.
5. Spector TD, James IT, Hall GM, Thompson PW, Perrett D, Hart DJ. Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Clin Rheumatol 1993;12:240-4.
6. Kollcrup G, Hansen M, Hørslev-Petersen K. Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis: relations to disease activity and effects of methylprednisolone. Br J Rheumatol 1994;33:816-20.
7. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-5.
8. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
9. Sinigaglia L, Varenna M, Binelli L, et al. Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995;54:144-7.
10. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-8.
11. Gouch A. Sambrook P. Devlin J, et al. Osleoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
12. Cortet B. Flipo RM, Pigny P. et al. Is hone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 1998;25:2339-44.
13. Lane N. Goldring SR. Bone loss in rheumatoid arthritis: what role does inflammation play? J Rheumatol 1998;25:1251-3.
14. Hamilton JA, Butler DM, Stanton B. Cytokine interactions promoting DNA synthesis in human synovial fibroblasts. J Rheumatol 1994;21:797-803.
15. Manolagas SC. Role of cytokines in hone resorption. Bone 1995;Suppl 17:63s-7s.
16. Nemoto R, Nakamura I, Nishijima Y, et al. Serum pyridinoline crosslinks as markers of tumour-induced bone resorption. Br J Urol 1997;80:274-80.
17. Arnett FC, Edworthy SM, Blooh DA, et al. The American Rheumatism Association 1987 revised criteria lor the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957;16:494-502.
19. 2D/25-OH-D ratio in SF of patients with rheumatoid arthritis. Life Sci 1997;61:977-85.
20. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
21. Robins SP, Black D, Paterson CR, Reid DM. Duncan A, Seibel MJ. Evaluation of urinary hydroxpyridinium crosslinks measurements as resorption markers in metabolic bone disease. Eur J Clin Invest 1991;21:310-5.
22. McLaren AM, Hordon LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of hone fracture. Ann Rheum Dis 1992;51:648-51.
23. Goto M, Sasano M, Yamanaka H, et al. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 1987;80:786-96.
24. Miyasaka N, Sato K, Goto M, et al. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Arthritis Rheum 1988;31:480-6.
25. Desmoulins D, Ponteziere Ch. Agneray J, Ekindjian OG, Cals MJ. Effects of human recombinant 1L-1ß on rheumatoid and non rheumatoid human synovial cell growth. Cell Moll Biol 1990;36:309-16.
26. 2 production by human synovial cells. J Clin Invest 1986;77:645-8.
27. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:163-4.
28. Harigai M, Hara M, Norioka K, et al. Stimulation of interleukin 6-like B-cell differentiation factor production in human adherent synovial cells by recombinant interleukin 1. Scand J Immunol 1989;29:289-97.
29. Gowen M, Wood DD, Ihrie EJ, McGuire MKB. Russell RGG. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983;306:378-80.
30. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990;144:4226-30.
31. Als OS, Christiansen C, Hellensen C. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment. Clin Rheumatol 1984;3:201-8.
32. Sambrook PN, Ansell BM. Forester S, Gumpel JM, Hesp R, Reeve J. Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis 1985;44:58-4.
33. Otterness IG, Pazoles PP, Moore PF, Pepys MB. C-reactive protein as an index of disease activity: comparison of tenidap, cyclophospharnide and dexamethasone in rat adjuvant arthritis. J Rheumatol 1991;18:505-11.
34. Magaro M, Tricerri A, Plane D, et al. Generalized osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int 1991;11:73-6.
35. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85.
36. Takahashi M, Kushida K, Hoshino H, et al. Concentrations of pyridinoline and deoxypyridinoline in joint tissues from patients with osteoarthritis or rheumatoid arthritis. Ann Rheum Dis 1996;55:324-7.